Hormone therapy risks are lower for women close to menopause

02/19/2010 | Medscape (free registration)

The benefit-risk profile for hormone therapy is better for women close to menopause but decreases over time as women age, according to a position statement by the North American Menopause Society. The updated guidelines include new sections on discontinuing HT and HT and ovarian and lung cancer.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD